308
Views
0
CrossRef citations to date
0
Altmetric
STUDY PROTOCOL

Determining the Efficacy and Safety of Acupuncture for the Preventive Treatment of Menstrual Migraine: A Protocol for a PRISMA-Compliant Systematic Review and Meta-Analysis

, , , , ORCID Icon &
Pages 101-109 | Received 24 Oct 2022, Accepted 17 Dec 2022, Published online: 10 Jan 2023

References

  • Zhang Y, Wang H, Liu L. Patent foramen ovale closure for treating migraine: a meta-analysis. J Interv Cardiol. 2022;2022:6456272. doi:10.1155/2022/6456272
  • Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi:10.1016/S0140-6736(15)60692-4
  • Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. Cephalalgia. 2018;38(1):1–211. doi:10.1177/0333102417738202
  • Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol. 2010;9(3):309–317. doi:10.1016/S1474-4422(09
  • GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954–976. doi:10.1016/S1474-4422(18)30322-3
  • Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177–189. doi:10.1007/s10194-012-0424-y
  • Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267(1):64–69. doi:10.1001/jama.1992.03480010072027
  • Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. Cephalalgia. 2013;33(9):629–808. doi:10.1177/0333102413485658
  • Peck KR, Johnson YL, Smitherman TA. Migraine. Handb Clin Neurol. 2016;138:283–293. doi:10.1016/B978-0-12-802973-2.00016-1
  • Bigal ME, Edvinsson L, Rapoport AM, et al. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol. 2015;14(11):1091–1100. doi:10.1016/S1474-4422(15)00245-8
  • Uygunoglu U, Siva A. Epidemiology of Headache//Dimos D, Mitsikostas, Koen Paemeleire. Pharmacol Management Headaches. 2016;7:17.
  • Pavlović JM, Stewart WF, Bruce CA, et al. Burden of migraine related to menses: results from the AMPP study. J Headache Pain. 2015;16:24. doi:10.1186/s10194-015-0503-y
  • Peterlin BL, Gupta S, Ward TN, et al. Sex matters: evaluating sex and gender in migraine and headache research. Headache. 2011;51(6):839–842. doi:10.1111/j.1526-4610.2011.01900.x
  • Delaruelle Z, Ivanova TA, Khan S, et al. Male and female sex hormones in primary headaches. J Headache Pain. 2018;19(1):117. doi:10.1186/s10194-018-0922-7
  • Allais G, Chiarle G, Sinigaglia S, et al. Menstrual migraine: a review of current and developing pharmacotherapies for women. Expert Opin Pharmacother. 2018;19(2):123–136. doi:10.1080/14656566.2017.1414182
  • Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008;71(22):1821–1828. doi:10.1212/01.wnl.0000335946.53860.1d
  • Bigal ME, Borucho S, Serrano D, et al. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009;29(8):891–897. doi:10.1111/j.1468-2982.2008.01819.x
  • Chen LN, Zhu W, Lin Y, et al. Balance acupuncture for females with menstrual migraine: a clinical study. J Guangzhou Univ Trad Chine Med. 2011;28:379–381+387.
  • Wang LH, Li DH, Zhang JQ, et al. Clinical effect of Shuitu acupoint transcutaneous electric nerve stimulation combined with acupoint injection on menstrual migraine: a randomized controlled observation. Modern J Integrated Trad Chine Western Med. 2015;24:1829–1831+1834. doi:10.3969/j.issn.1008-8849.2015.17.002
  • Tian LQ, Li L. Acupuncture at the starting and ending points of Liver-Gall bladder meridians for menstrual migraine: a clinical study. J Clin Acupuncture Moxibustion. 2014;30:7–9. doi:10.3969/j.issn.1005-0779.2014.05.003
  • Liu L, Zhang CS, Liu HL, et al. Acupuncture for menstruation-related migraine prophylaxis: a multicenter randomized controlled trial. Front Neurosci. 2022;16:992577. doi:10.3389/fnins.2022.992577
  • Zhang Y, Wang Z, Du J, et al. Regulatory effects of acupuncture on emotional disorders in patients with menstrual migraine without aura: a resting-state fMRI study. Front Neurosci. 2021;15:726505. doi:10.3389/fnins.2021.726505
  • Yu X, Salmoni A. Comparison of the prophylactic effect between acupuncture and acupressure on menstrual migraine: results of a pilot study. J Acupunct Meridian Stud. 2018;11(5):303–314. doi:10.1016/j.jams.2018.04.003
  • Yang M, Du T, Long H, et al. Acupuncture for menstrual migraine: a systematic review. BMJ Support Palliat Care. 2020. doi:10.1136/bmjspcare-2019-002024
  • Liu LY. Treatment of menstrual migraine with warming acupuncture and moxibustion. Shanxi Univ Chine Med. 2020. doi:10.27820/d.cnki.gszxy.2020.000055
  • Du EY, Wang N. Clinical observation of acupuncture treatment of menstrually related migraine. Chine Commun Doctors. 2022;38(09):69–71.
  • Yan JX, Wang Q, Liao ZL, et al. Treatment of menstrual migraine patients with Qi stagnation blood stasis syndrome by acupuncture and medicines: a randomized controlled trial. Chine J Integrated Trad Western Med. 2021;41(12):1511–1513.
  • Xing R, Zhang SX. Observation on acupuncture combined with blood-letting therapy in the treatment of menstrual headache of the liver fire syndrome. Jilin J Chine Med. 2020;40(12):1659–1662. doi:10.13463/j.cnki.jlzyy.2020.12.033
  • Li XF, Yu M. Clinical study on the treatment of menstrual migraine by acupuncture taichong and yongquan points. J Xi’an Jiaotong Univ. 2019;40(05):834–838. doi:10.7652/jdyxb201905033
  • Allais G, Bussone G, Tullo V, et al. Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial. Cephalalgia. 2015;35(1):45–50. doi:10.1177/0333102414542290
  • Hu Y, Guan X, Fan L, et al. Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain. 2013;14(1):7. doi:10.1186/1129-2377-14-7
  • Nierenburg Hdel C, Ailani J, Malloy M, et al. Systematic review of preventive and acute treatment of menstrual migraine. Headache. 2015;55(8):1052–1071. doi:10.1111/head.12640
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi:10.1186/2046-4053-4-1
  • Lee CJ, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis of intervention studies. J Diabetes Complications. 2017;31(7):1115–1126. doi:10.1016/j.jdiacomp.2017.04.019
  • Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia. 2004;24:9–160. doi:10.1111/j.1468-2982.2003.00824.x
  • Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:1–96.
  • Worthington I, Pringsheim T, Gawel MJ, et al. Canadian Headache Society guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013;40(5 Suppl 3):S1–S80. doi:10.1017/S0317167100017819
  • American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1–18. doi:10.1111/head.13456
  • Pringsheim T, Davenport W, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):S1–S59.
  • Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of migraine. 2018. Available from: http://www.sign.ac.uk. Accessed January 4, 2023.
  • National Institute for Health and Care Excellence (NICE). Diagnosis and management of headaches in young people and adults: evidence update October 2014. Available from: https://www.evidence.nhs.uk/search?q=Diagnosis+and+manageme. Accessed January 4, 2023. nt+of+headaches+in+young+people+and+adults.
  • Ou MQ, Fan WH, Sun FR, et al. A systematic review and meta-analysis of the therapeutic effect of acupuncture on migraine. Front Neurol. 2020;11:596. doi:10.3389/fneur.2020.00596
  • Jiang Y, Bai P, Chen H, et al. The effect of acupuncture on the quality of life in patients with migraine: a systematic review and meta-analysis. Front Pharmacol. 2018;9:1190. doi:10.3389/fphar.2018.01190
  • Xu J, Zhang FQ, Pei J, et al. Acupuncture for migraine without aura: a systematic review and meta-analysis. J Integr Med. 2018;16(5):312–321. doi:10.1016/j.joim.2018.06.002
  • Higgins J, Thomas. J. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collab. 2011;10:1465.
  • Flemyng E, Dwan K, Moore TH, et al. Risk of bias 2 in Cochrane reviews: a phased approach for the introduction of new methodology. Cochrane Database Syst Rev. 2020;10:Ed000148. doi:10.1002/14651858.ED000148
  • Brozek JL, Akl EA, Alonso-Coello P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64(5):669–677. doi:10.1111/j.1398-9995.2009.01973.x
  • Gang WJ, Gong CZ, Jing XH. Acupuncture randomized controlled trials: comparing China-based vs Western-based studies. Zhongguo Zhen Jiu. 2022;42(1):3–7. doi:10.13703/j.0255-2930.20201224-k0001